Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical Imaging

PUBLISHER: Grand View Research | PRODUCT CODE: 1609588

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1609588

Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Modality (Computed Tomography Scan, Magnetic Resonance Imaging), By Therapeutic Area, By Services, By End Use, Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Clinical Trial Imaging Market Growth & Trends:

The global clinical trial imaging market size is expected to reach USD 1.91 billion by 2030, registering a CAGR of 7.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

Clinical Trial Imaging Market Report Highlights:

  • The reading and analytical services segment held the largest market share at 30.95% in 2024 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, highlighting its critical role in ensuring the accuracy and reliability of imaging data in clinical research.
  • The biotechnology and pharmaceutical companies segment accounted for the largest share of 28.7% in 2024. The factor attributing to the dominance of this segment is the need to develop new drugs and therapies to cure chronic diseases.
  • Oncology segment held the largest market share of 23.63% in 2024. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.
  • The contract research organizations (CROs) segment is expected to grow significantly with a CAGR of 8.5% over the forecast period, owing to its essential role in developing new drugs and therapies for chronic diseases.
  • North America dominated the market with a revenue share of 47.93% in 2024 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.
Show more
Product Code: GVR-2-68038-628-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Therapeutic Area
    • 1.2.3. Services
    • 1.2.4. End Use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Therapeutic area outlook
    • 2.2.3. Services outlook
    • 2.2.4. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Clinical Trial Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing number of pharmaceutical and biotechnological companies
      • 3.2.1.2. Growing number of contract research organization (CRO)
      • 3.2.1.3. Increasing research and development investments
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of machineries and installations
  • 3.3. Clinical Trial Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Clinical Trial Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Clinical Trial Imaging Market: Modality Movement Analysis
  • 4.3. Clinical Trial Imaging Market by Modality Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Computed Tomography Scan
    • 4.5.1. Computed Tomography Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Magnetic Resonance Imaging
    • 4.6.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. X-Ray
    • 4.7.1. X-Ray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Ultrasound
    • 4.8.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Optical Coherence Tomography (OCT)
    • 4.9.1. Optical Coherence Tomography (OCT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Other Modalities
    • 4.10.1. Other Modalities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Imaging Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Clinical Trial Imaging Market: Therapeutic Area Movement Analysis
  • 5.3. Clinical Trial Imaging Market by Therapeutic Area Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Neurovascular Diseases
    • 5.5.1. Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cardiovascular Diseases
    • 5.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Orthopedics & MSK Disorders
    • 5.7.1. Orthopedics & MSK Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Oncology
    • 5.8.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Ophthalmology
    • 5.9.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Nephrology
    • 5.10.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Other Therapeutic Areas
    • 5.11.1. Other Therapeutic Areas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Imaging Market: Services Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Clinical Trial Imaging Market: Services Movement Analysis
  • 6.3. Clinical Trial Imaging Market by Services Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Clinical Trial Design and Consultation Services
    • 6.5.1. Clinical Trial Design and Consultation Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Reading and Analytical Services
    • 6.6.1. Reading and Analytical Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Operational Imaging Services
    • 6.7.1. Operational Imaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. System and Technology Support Services
    • 6.8.1. System and Technology Support Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Project and Data Management
    • 6.9.1. Project and Data Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Imaging Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Clinical Trial Imaging Market: End Use Movement Analysis
  • 7.3. Clinical Trial Imaging Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Biotechnology and Pharmaceutical Companies
    • 7.5.1. Biotechnology and Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Medical Devices Manufacturers
    • 7.6.1. Medical Devices Manufacturers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Academic and Government Research Institutes
    • 7.7.1. Academic and Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Contract Research Organizations (CROs)
    • 7.8.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Other End Users
    • 7.9.1. Other End Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.8.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.8. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. Middle East & Africa
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
    • 9.1.1 Company/Competition Categorization
    • 9.1.2. Innovators
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
    • 9.2.2. Key customers
    • 9.2.3. Key company market share analysis, 2024
    • 9.2.4. IXICO plc
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Navitas Life Sciences
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Resonance Health
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. ProScan Imaging
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Radiant Sage LLC
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Medpace
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Biomedical Systems Corp.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Cardiovascular Imaging Technologies
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Intrinsic Imaging
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. BioTelemetry
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives
Show more
Product Code: GVR-2-68038-628-8

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 5 North America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 6 North America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 9 U.S. clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 10 U.S. clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 12 Canada clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 13 Canada clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 14 Canada clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 16 Mexico clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 17 Mexico clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 18 Mexico clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 21 Europe clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 22 Europe clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 23 Europe clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 25 Germany clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 26 Germany clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 27 Germany clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 28 UK clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 29 UK clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 30 UK clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 31 UK clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 32 France clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 33 France clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 34 France clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 35 France clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Italy clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 37 Italy clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 38 Italy clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 39 Italy clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Spain clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 41 Spain clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 42 Spain clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 43 Spain clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Sweden clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Sweden clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 46 Sweden clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 47 Sweden clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Denmark clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 49 Denmark clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 50 Denmark clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 51 Denmark clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Norway clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 53 Norway clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 54 Norway clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 55 Norway clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 61 China clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 62 China clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 63 China clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 64 China clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Japan clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 66 Japan clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 67 Japan clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 68 Japan clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 69 India clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 70 India clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 71 India clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 72 India clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Australia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 74 Australia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 75 Australia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 76 Australia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 77 South Korea clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 78 South Korea clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 79 South Korea clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 80 South Korea clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Thailand clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 82 Thailand clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 83 Thailand clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 84 Thailand clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 86 Latin America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 87 Latin America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 88 Latin America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 89 Latin America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Brazil clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 91 Brazil clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 92 Brazil clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 93 Brazil clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 95 Argentina clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 96 Argentina clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 97 Argentina clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 103 South Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 104 South Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 105 South Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 106 South Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 112 UAE clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 113 UAE clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 114 UAE clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 116 Kuwait clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 117 Kuwait clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 118 Kuwait clinical trial imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 clinical trial imaging market: market outlook
  • Fig. 14 clinical trial imaging market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical trial imaging market driver impact
  • Fig. 20 Clinical trial imaging market restraint impact
  • Fig. 21 Clinical trial imaging market strategic initiatives analysis
  • Fig. 22 Clinical trial imaging market: Modality movement analysis
  • Fig. 23 Clinical trial imaging market: Modality outlook and key takeaways
  • Fig. 24 Computed tomography scan market estimates and forecast, 2018 - 2030
  • Fig. 25 Magnetic resonance imaging market estimates and forecast, 2018 - 2030
  • Fig. 26 X-Ray market estimates and forecast, 2018 - 2030
  • Fig. 27 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 28 Optical coherence tomography (OCT) market estimates and forecast, 2018 - 2030
  • Fig. 29 Other modalities market estimates and forecast, 2018 - 2030
  • Fig. 30 Clinical trial imaging market: Therapeutic area movement analysis
  • Fig. 31 Clinical trial imaging market: Therapeutic area outlook and key takeaways
  • Fig. 32 Neurovascular diseases market estimates and forecast, 2018 - 2030
  • Fig. 33 Cardiovascular diseases market estimates and forecast, 2018 - 2030
  • Fig. 34 Oncology market estimates and forecast, 2018 - 2030
  • Fig. 35 Ophthalmology market estimates and forecast, 2018 - 2030
  • Fig. 36 Nephrology market estimates and forecast, 2018 - 2030
  • Fig. 37 Other therapeutic areas market estimates and forecast, 2018 - 2030
  • Fig. 38 Clinical trial imaging market: Services movement analysis
  • Fig. 39 Clinical trial imaging market: Services outlook and key takeaways
  • Fig. 40 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
  • Fig. 41 Reading and analytical services market estimates and forecast, 2018 - 2030
  • Fig. 42 Operational imaging services market estimates and forecast, 2018 - 2030
  • Fig. 43 System and technology support services market estimates and forecast, 2018 - 2030
  • Fig. 44 Project and data management market estimates and forecast, 2018 - 2030
  • Fig. 45 Clinical trial imaging market: End use movement analysis
  • Fig. 46 Clinical trial imaging market: End use outlook and key takeaways
  • Fig. 47 Biotechnology companies market estimates and forecast, 2018 - 2030
  • Fig. 48 Medical devices manufacturers market estimates and forecast, 2018 - 2030
  • Fig. 49 Academic and government research institutes market estimates and forecast, 2018 - 2030
  • Fig. 50 Contract research organizations (CROs) market estimates and forecast, 2018 - 2030
  • Fig. 51 Other end users market estimates and forecast, 2018 - 2030
  • Fig. 52 Global clinical trial imaging market: Regional movement analysis
  • Fig. 53 Global clinical trial imaging market: Regional outlook and key takeaways
  • Fig. 54 Global market shares and leading players
  • Fig. 55 North America market share and leading players
  • Fig. 56 Europe market share and leading players
  • Fig. 57 Asia Pacific market share and leading players
  • Fig. 58 Latin America market share and leading players
  • Fig. 59 Middle East & Africa market share and leading players
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecast, 2018 - 2030
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecast, 2018 - 2030
  • Fig. 66 Mexico
  • Fig. 67 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 68 Europe
  • Fig. 69 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 70 UK
  • Fig. 71 UK market estimates and forecast, 2018 - 2030
  • Fig. 72 Germany
  • Fig. 73 Germany market estimates and forecast, 2018 - 2030
  • Fig. 74 France
  • Fig. 75 France market estimates and forecast, 2018 - 2030
  • Fig. 76 Italy
  • Fig. 77 Italy market estimates and forecast, 2018 - 2030
  • Fig. 78 Spain
  • Fig. 79 Spain market estimates and forecast, 2018 - 2030
  • Fig. 80 Sweden
  • Fig. 81 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 82 Denmark
  • Fig. 83 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 84 Norway
  • Fig. 85 Norway market estimates and forecast, 2018 - 2030
  • Fig. 86 Asia Pacific
  • Fig. 87 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 88 China
  • Fig. 89 China market estimates and forecast, 2018 - 2030
  • Fig. 90 Japan
  • Fig. 91 Japan market estimates and forecast, 2018 - 2030
  • Fig. 92 India
  • Fig. 93 India market estimates and forecast, 2018 - 2030
  • Fig. 94 Australia
  • Fig. 95 Australia market estimates and forecast, 2018 - 2030
  • Fig. 96 South Korea
  • Fig. 97 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 98 Thailand
  • Fig. 99 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 100 Latin America
  • Fig. 101 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 102 Brazil
  • Fig. 103 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 104 Argentina
  • Fig. 105 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 106 Middle East and Africa
  • Fig. 107 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 108 Saudi Arabia
  • Fig. 109 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 110 South Africa
  • Fig. 111 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 112 UAE
  • Fig. 113 UAE market estimates and forecast, 2018 - 2030
  • Fig. 114 Kuwait
  • Fig. 115 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 116 Participant categorization- Clinical trial imaging market
  • Fig. 117 Market share of key market players- Clinical trial imaging market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!